NEPHROS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
NEPHROS, INC. (NEPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.13 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-12
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $1.13, a 19.29% decline from fiscal 2024.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $1.40, a 41.41% increase from fiscal 2023.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $0.99, a 20.80% decline from fiscal 2022.
- NEPHROS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $1.25, a 74.70% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.13 10-K · filed 2026-03-12 | |
| 2024-12-31 | $1.40 10-K · filed 2026-03-12 | |
| 2023-12-31 | $0.99 10-K · filed 2025-03-24 | |
| 2022-12-31 | $1.25 10-K · filed 2024-03-15 | |
| 2021-12-31 | $4.94 10-K · filed 2023-03-23 | |
| 2020-12-31 | $4.45 10-K · filed 2022-03-03 | |
| 2019-12-31 | $5.05 10-K · filed 2021-03-01 | |
| 2018-12-31 | $4.32 10-K · filed 2020-02-27 | $0.48 10-K · filed 2019-03-12 |
| 2017-12-31 | $0.36 10-K · filed 2019-03-12 | |
| 2016-12-31 | $0.31 10-K · filed 2018-02-26 | |
| 2015-12-31 | $0.49 10-K · filed 2017-03-20 | $0.56 10-K · filed 2016-03-30 |
| 2014-12-31 | $0.45 10-K · filed 2016-03-30 | |
| 2013-12-31 | $0.56 10-K · filed 2015-04-15 | |
| 2012-12-31 | $1.03 10-K · filed 2014-03-28 | |
| 2011-12-31 | $0.45 10-K · filed 2013-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |